A Plainview software development firm CEO says AI use will allow him to trim his 200-staff operation by more than half.

This new “thinking model” outperforms OpenAI o3 mini, GPT-4.5, DeepSeek-R1, Grok 3 and Claude 3.7 Sonnet in several ...

At this year’s NAB Show, Sonnet will showcase its first Thunderbolt 5 products, present first looks at its 2024 Mac mini ...

Anthropic’s Claude Sonnet 3.7 with reasoning displayed the behavior much more often than generative AI models without ...

SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy, ...

The Arc Prize Foundation has a new test for AGI that leading AI models from Anthropic, Google, and DeepSeek score poorly on.

Sonnet BioTherapeutics (SONN) announced positive findings from the first safety review of the expansion cohort in its Phase 1 SB101 clinical ...

Sonnet BioTherapeutics has a fifty-two week low of $1.30 and a fifty-two week high of $17.84. Get Sonnet BioTherapeutics alerts: Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report ...

AI is your hub for some of the most popular AI models around for advanced content tasks, nuanced and creative writing, and ...